Structural diversity of mucins : Significance in infection and immunity
Structural diversity of mucins : Significance in infection and immunity
批准号:
12307054
负责人:
IRIMURA Tatsuro
金额:
$27.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003
中文摘要
这一提议的具体目的是证明或反驳一种假说,粘蛋白是具有高度O-糖基化的上皮表面糖蛋白,作为对抗原生动物、细菌和病毒等寄生虫的特定防御分子。得到以下结论:(1)上皮粘蛋白的糖基化谱高度多样化。(2)粘蛋白的特异性糖基化受多个UDP-GalNAc-多肽N-乙酰半乳糖胺转移酶(PpGalNAc Ts)的协同作用高度调节。(3)Th2细胞因子IL-4显著增强几个ppGalNAc的表达(ppGalNAc T1、4和7),导致粘蛋白2的糖基化谱改变。(4)这种改变后,分泌的粘蛋白改变了与凝集素的反应活性,(5)利用重组ppGalNAc-ts和其他糖基转移酶在体外制备了各种寡糖-多肽复合体。它们被用来确定凝集素对粘蛋白基序的特异性。(6)病原体上的粘蛋白基序的变化也被证明在感染过程中起着重要的调节作用。(7)在这些过程中,巨噬细胞和树突状细胞上的C型/半乳糖型凝集素被显著参与。
英文摘要
The specific aim of this proposal was to prove or disprove a hypothesis whether mucins, epithelial surface glycoproteins with a high degree of O-glycosylation, played roles as specific defense molecules against parasites, such as protozoa, bacteria, and viruses. The following conclusions were obtained.(1)Epithelial mucins were highly diverse in their glycosylation profiles.(2)The specific glycosylation of mucins were regulated in a high degree of fidelity by concerted actions of multiple UDP-GalNAc-polypeptide N-acetylgalactosaminyltransferases (ppGalNAc Ts).(3)A Th2 cytokine, IL-4, drastically enhance the expression of a few ppGalNAc Ts (ppGalNAc T1, 4, and 7), which resulted in an alteration of glycosylation profiles of mucin 2.(4)After such alterations, the secreted mucins changed its reactivity with lectins, carbohydrate-binding proteins.(5)Various oligosaccharide-polypeptide complexes were prepared by the use of recombinant ppGalNAc Ts and other glycosyltransferases in vitro. They were tested to determine the specificity of lectins toward mucin motifs.(6)Variations in mucin motifs on pathogens, such as the surface coat glycoproteins of Ebola virus, were also shown to play important roles in the regulation of infective processes.(7)In these processes, C-type/galactose-type lectins on macrophages and dendritic cells were shown to be significantly involved.
期刊论文(65)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.: "Expression of UDP-N Acetylgalactosaminyl transferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathologic
Miyahara N、Shoda J、Kawamoto T、Furukawa M、Ueda T、Todoroki T、Tanaka N、Matsuo K、Yamada Y、Kohno K、Irimura T.:“浆膜下层中 UDP-N 乙酰半乳糖胺基转移酶同工酶 3 的表达与
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Horinouchi M, Nagata K, Nakamura A, Goto M, Takao S, Sakamoto M, Fukushima N, Miwa A, Irimura T, Imai K, Sato E, Yonezawa S.: "Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUCSAC and MUC6) in Pancreatic Neoplasms.
Horinouchi M、Nagata K、Nakamura A、Goto M、Takao S、Sakamoto M、Fukushima N、Miwa A、Irimura T、Imai K、Sato E、Yonezawa S.:“膜粘蛋白(MUC1)和分泌物的不同糖型的表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Bando T: "Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy"J Gastroenterol.. 37. 260-269 (2002)
Bando T:“可通过红外荧光内窥镜检测的标记抗粘蛋白抗体的基础研究”J Gastroenterol.. 37. 260-269 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Onami TM: "The generation of mice deficient for the macrophage galactose and N-acetylgalactosamine specific lectin : limited role in lymphoid and erythroid homeostasis, and evidence for multiple lectins"Mol Cell Biol.. 22. 5173-5181 (2002)
Onami TM:“巨噬细胞半乳糖和 N-乙酰半乳糖胺特异性凝集素缺陷的小鼠的产生:在淋巴和红细胞稳态中的有限作用,以及多种凝集素的证据”Mol Cell Biol.. 22. 5173-5181 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 61 条
Development of cancer stem cells driven by microenvironment
-
批准号:26670023
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:IRIMURA Tatsuro
-
依托单位:
MUC21 glycoforms as the target of cancer diagnosis and therapy
-
批准号:25293011
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2013
-
负责人:IRIMURA Tatsuro
-
依托单位:
Regulation of IgA responses against influenza virus
-
批准号:24659029
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:IRIMURA Tatsuro
-
依托单位:
A peptide sequence motif which regulates glycoforms
-
批准号:22659016
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.98万
-
财政年份:2010
-
负责人:IRIMURA Tatsuro
-
依托单位:
Immune-suppressive function of cancer-associated mucin epiglycanin/Muc21
-
批准号:21390018
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:IRIMURA Tatsuro
-
依托单位:
Establishment of hepatic metastasis model of pancreatic carcinoma and it application to the development of therapeutic agents
-
批准号:11557180
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:1999
-
负责人:IRIMURA Tatsuro
-
依托单位:
Regulation of cellular trafficking and pathogenesis by mucins
-
批准号:07407063
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.41万
-
财政年份:1995
-
负责人:IRIMURA Tatsuro
-
依托单位:
Establishment of Detection Systems and Expression Systems for Organ-Specific Mucins
-
批准号:05557104
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.23万
-
财政年份:1993
-
负责人:IRIMURA Tatsuro
-
依托单位:
Cell surface glycoconjugates and adhesion molecules
-
批准号:04454591
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1992
-
负责人:IRIMURA Tatsuro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Red/ET重组BCAS1工程菌的构建及通过MUC2调控缓解仔猪腹泻的机制研究
-
批准号:2026JJ70027
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雁灿
-
依托单位:
螺旋藻外泌体膜蛋白重排调控多价配体簇靶向MUC2的递送增效机制
-
批准号:32572573
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:李书红
-
依托单位:
基于ST6介导的MUC2唾液酸化修饰探讨艾灸对UC及伴发情绪失调“肠脑同治”的关键机制
-
批准号:82560976
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:董龙聪
-
依托单位:
辐射诱导肠道杯状细胞内质网应激调控黏蛋白MUC2分泌的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:谢黎伟
-
依托单位:
茯砖茶多酚通过Akkermansia muciniphila调控肠道黏蛋白MUC2改善高脂饮食诱导肠道屏障损伤机制研究
-
批准号:32402114
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:周方
-
依托单位:
“苦能燥湿”药性理论下香连丸调节苦味受体介导MUC2唾液酸化重塑UC肠黏液屏障作用的机制研究
-
批准号:82474526
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:赵敏
-
依托单位:
苦燥湿药性理论下善连丸调节苦味受体介导MUC2唾液酸化重塑UC肠黏液屏障作用的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:赵敏
-
依托单位:
PDCoV下调ST6GALNAC1抑制MUC2唾液酸化破坏肠道黏液层的分子机制
-
批准号:32473119
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:李基棕
-
依托单位:
新功能型乳酸菌调节“树突状细胞—哨兵杯状细胞-MUC2”轴影响ETEC感染的分子免疫机制研究
-
批准号:32473067
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:张冬星
-
依托单位:
巯基介导的花色苷/豌豆白蛋白递送体系与肠道粘蛋白MUC2的粘附作用机制研究
-
批准号:32372360
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:季俊夫
-
依托单位: